In a recent study, high BMI, a widely used index of obesity, was an independent factor associated with a high 21-gene recurrence score in estrogen receptor (ER)–positive, ERBB2-negative young (≤45 years) breast cancer patients [14]. The gene discussed is ESR1; the disease is obesity due to melanocortin 4 receptor deficiency.